Diagnostic performance and safety of NMK36 (trans-1-amino-3-[18F] fluorocyclobutanecarboxylic acid)-PET/CT in primary prostate pancer: multicenter Phase IIb clinical trial

Jpn J Clin Oncol. 2017 Mar 1;47(3):283. doi: 10.1093/jjco/hyw177.
No abstract available

Publication types

  • Published Erratum